bioMérieux Sweden AB
556266-0653ActiveWorld leader developing in vitro diagnostics for health and safety.
Yleiskatsaus
- 20–49
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 1985
- Perustettu
Avainpäättäjät
Pierre Boulud
Chief Executive Officer
Charles K. Cooper
Executive Vice President, Chief Medical Officer
Audrey Dauvet
Executive Vice President, Legal, Corporate Integrity & Public Affairs
Bénédicte Blot
Vice President, HSE
+13 lisää yhteystietoja Funnelfeedrissä
Kuvaus
bioMérieux is a family-owned company recognized globally as a world leader in the field of in vitro diagnostics (IVD). Their core mission is dedicated to improving public health worldwide through pioneering diagnostic solutions. The company specializes in clinical applications, providing healthcare...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Partihandel med mät- och precisionsinstrument
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556266065301
Päättäjät
17 yhteystietoa FunnelfeedrissäPierre Boulud
Chief Executive Officer
Charles K. Cooper
Executive Vice President, Chief Medical Officer
Audrey Dauvet
Executive Vice President, Legal, Corporate Integrity & Public Affairs
Bénédicte Blot
Vice President, HSE
Valérie Leyldé
Executive Vice President, Human Resources, Communication & CSR
Yasha Mitrotti
Executive Vice President, Industrial Applications
Alexandre Mérieux
Chairman of the Board of Directors
Alain Mérieux
Founding President
Sylvain Orenga
Director representing employees
Jennifer Zinn
Executive Vice President, Clinical Operations
Céline Roger-Dalbert
Executive Vice President, Research & Development
Pierre Charbonnier
Executive Vice President, Global Quality, Manufacturing and Supply Chain
Guillaume Bouhours
Chief Financial Officer, Executive Vice President, Purchasing and Information Systems
Muut yhteyshenkilöt
Olivier Rescanière
Media Contact
Romain Duchez
Media Contact
Kevin L. Williams
Technical Expert
Christian Faderl
Technical Expert
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäLumiraDx Aktiebolag
3 työntekijätGlobal leader providing advanced in-vitro diagnostic solutions at the point of need.
CERUS EUROPE BV
1–4 työntekijätCerus Corporation develops vital technologies to secure the global blood supply.
Gradientech AB
20–49 työntekijätDeveloping ultra-rapid diagnostic systems for antibiotic susceptibility testing.
Sangair AB
3 työntekijätDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Amferia AB
5–9 työntekijätDeveloping peptide hydrogel technology to combat bacterial infections safely.
Selaa lisää
Kysymyksiä yrityksestä bioMérieux Sweden AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo